The future of faecal transplants-Reference-Cited by-同舟云学术

The future of faecal transplants

Published:2019-09-18 Issue:12 Volume:17 Page:719-719
ISSN:1740-1526
Container-title:Nature Reviews Microbiology
language:en
Short-container-title:Nat Rev Microbiol

Author:

Giles Edward M.,D’Adamo Gemma L.,Forster Samuel C.

Publisher

Springer Science and Business Media LLC

Subject

General Immunology and Microbiology,Microbiology,Infectious Diseases

Link

http://www.nature.com/articles/s41579-019-0271-9.pdf

Reference6 articles.

1. FDA. Important Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms. Fda.gov https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse (2019).

2. Baxter, M. et al. Fatal aspiration pneumonia as a complication of fecal microbiota transplant. Clin. Infect. Dis. 61, 136–137 (2015).

3. Kelly, C. R. et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am. J. Gastroenterol. 109, 1065–1071 (2014).

4. Solari, P. R. et al. Tempered enthusiasm for fecal transplant. Clin. Infect. Dis. 59, 319 (2014).

5. Cammarota, G. et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66, 569 (2017).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiota and glioma: a new perspective from association to clinical translation;Gut Microbes;2024-08-26

2. Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis;Advanced Materials;2024-07-29

3. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy;Immunity, Inflammation and Disease;2024-07

4. Bacteria/Nanozyme Composites: New Therapeutics for Disease Treatment;Small Methods;2024-06-25

5. A Review of Clinical Trials Involving Genetically Modified Bacteria, Bacteriophages and Their Associated Risk Assessments;Applied Biosafety;2024-05-08